DXC Technology director receives 30,900 RSUs
Herzog David L reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Herzog David L reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology Co director David L. Herzog received a grant of 30,900 restricted stock units (RSUs) representing common stock on August 4, 2026. Each RSU entitles him to one share of common stock and will vest on the earlier of one year from the grant date or the 2027 annual meeting of stockholders, with settlement at vesting or a deferred date if elected.
After this award, Herzog directly holds 147,301 shares of DXC common stock, and this amount includes unvested RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 30,900 | $0.00 | $0.00 |
Footnotes (2)
- F1. Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the 2027 annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.
- F2. Amount reported includes unvested RSUs.
Key Figures
Key Terms
restricted stock units (RSUs) financial
vest financial
defer settlement financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did David L. Herzog report for DXC (DXC)?
What is the vesting schedule of the 30,900 RSUs granted to the DXC (DXC) director?
Are the RSUs granted to the DXC (DXC) director settled immediately?
Does this DXC (DXC) Form 4 include any derivative option exercises or sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.